99 related articles for article (PubMed ID: 38618957)
1. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.
Hennighausen L; Robinson GW
Genes Dev; 2008 Mar; 22(6):711-21. PubMed ID: 18347089
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.
Berger A; Sexl V; Valent P; Moriggl R
Oncotarget; 2014 Oct; 5(20):9564-76. PubMed ID: 25333255
[TBL] [Abstract][Full Text] [Related]
3. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
[TBL] [Abstract][Full Text] [Related]
4. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
5. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
6. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation.
Welte T; Leitenberg D; Dittel BN; al-Ramadi BK; Xie B; Chin YE; Janeway CA; Bothwell AL; Bottomly K; Fu XY
Science; 1999 Jan; 283(5399):222-5. PubMed ID: 9880255
[TBL] [Abstract][Full Text] [Related]
7. STAT5BN642H is a driver mutation for T cell neoplasia.
Pham HTT; Maurer B; Prchal-Murphy M; Grausenburger R; Grundschober E; Javaheri T; Nivarthi H; Boersma A; Kolbe T; Elabd M; Halbritter F; Pencik J; Kazemi Z; Grebien F; Hengstschläger M; Kenner L; Kubicek S; Farlik M; Bock C; Valent P; Müller M; Rülicke T; Sexl V; Moriggl R
J Clin Invest; 2018 Jan; 128(1):387-401. PubMed ID: 29200404
[TBL] [Abstract][Full Text] [Related]
8. Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.
Kelly JA; Spolski R; Kovanen PE; Suzuki T; Bollenbacher J; Pise-Masison CA; Radonovich MF; Lee S; Jenkins NA; Copeland NG; Morse HC; Leonard WJ
J Exp Med; 2003 Jul; 198(1):79-89. PubMed ID: 12835478
[TBL] [Abstract][Full Text] [Related]
9. Arrayed CRISPR/Cas9 Screening for the Functional Validation of Cancer Genetic Dependencies.
Proietti L; Manhart G; Heyes E; Troester S; Grebien F
Bio Protoc; 2022 Dec; 12(24):. PubMed ID: 36618092
[TBL] [Abstract][Full Text] [Related]
10. A central role for STAT5 in the transcriptional programing of T helper cell metabolism.
Villarino AV; Laurence AD; Davis FP; Nivelo L; Brooks SR; Sun HW; Jiang K; Afzali B; Frasca D; Hennighausen L; Kanno Y; O'Shea JJ
Sci Immunol; 2022 Nov; 7(77):eabl9467. PubMed ID: 36427325
[TBL] [Abstract][Full Text] [Related]
11. Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
Sorger H; Dey S; Vieyra-Garcia PA; Pölöske D; Teufelberger AR; de Araujo ED; Sedighi A; Graf R; Spiegl B; Lazzeri I; Braun T; Garces de Los Fayos Alonso I; Schlederer M; Timelthaler G; Kodajova P; Pirker C; Surbek M; Machtinger M; Graier T; Perchthaler I; Pan Y; Fink-Puches R; Cerroni L; Ober J; Otte M; Albrecht JD; Tin G; Abdeldayem A; Manaswiyoungkul P; Olaoye OO; Metzelder ML; Orlova A; Berger W; Wobser M; Nicolay JP; André F; Nguyen VA; Neubauer HA; Fleck R; Merkel O; Herling M; Heitzer E; Gunning PT; Kenner L; Moriggl R; Wolf P
EMBO Mol Med; 2022 Dec; 14(12):e15200. PubMed ID: 36341492
[TBL] [Abstract][Full Text] [Related]
12. PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.
Garces de Los Fayos Alonso I; Zujo L; Wiest I; Kodajova P; Timelthaler G; Edtmayer S; Zrimšek M; Kollmann S; Giordano C; Kothmayer M; Neubauer HA; Dey S; Schlederer M; Schmalzbauer BS; Limberger T; Probst C; Pusch O; Högler S; Tangermann S; Merkel O; Schiefer AI; Kornauth C; Prutsch N; Zimmerman M; Abraham B; Anagnostopoulos J; Quintanilla-Martinez L; Mathas S; Wolf P; Stoiber D; Staber PB; Egger G; Klapper W; Woessmann W; Look TA; Gunning P; Turner SD; Moriggl R; Lagger S; Kenner L
Mol Cancer; 2022 Aug; 21(1):172. PubMed ID: 36045346
[TBL] [Abstract][Full Text] [Related]
13. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R; Amador C; Anagnostopoulos I; Attygalle AD; Araujo IBO; Berti E; Bhagat G; Borges AM; Boyer D; Calaminici M; Chadburn A; Chan JKC; Cheuk W; Chng WJ; Choi JK; Chuang SS; Coupland SE; Czader M; Dave SS; de Jong D; Du MQ; Elenitoba-Johnson KS; Ferry J; Geyer J; Gratzinger D; Guitart J; Gujral S; Harris M; Harrison CJ; Hartmann S; Hochhaus A; Jansen PM; Karube K; Kempf W; Khoury J; Kimura H; Klapper W; Kovach AE; Kumar S; Lazar AJ; Lazzi S; Leoncini L; Leung N; Leventaki V; Li XQ; Lim MS; Liu WP; Louissaint A; Marcogliese A; Medeiros LJ; Michal M; Miranda RN; Mitteldorf C; Montes-Moreno S; Morice W; Nardi V; Naresh KN; Natkunam Y; Ng SB; Oschlies I; Ott G; Parrens M; Pulitzer M; Rajkumar SV; Rawstron AC; Rech K; Rosenwald A; Said J; Sarkozy C; Sayed S; Saygin C; Schuh A; Sewell W; Siebert R; Sohani AR; Tooze R; Traverse-Glehen A; Vega F; Vergier B; Wechalekar AD; Wood B; Xerri L; Xiao W
Leukemia; 2022 Jul; 36(7):1720-1748. PubMed ID: 35732829
[TBL] [Abstract][Full Text] [Related]
14. Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia.
Braun T; Stachelscheid J; Bley N; Oberbeck S; Otte M; Müller TA; Wahnschaffe L; Glaß M; Ommer K; Franitza M; Gathof B; Altmüller J; Hallek M; Auguin D; Hüttelmaier S; Schrader A; Herling M
Cancer Res; 2022 May; 82(9):1818-1831. PubMed ID: 35259248
[TBL] [Abstract][Full Text] [Related]
15. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.
Cordo' V; van der Zwet JCG; Canté-Barrett K; Pieters R; Meijerink JPP
Blood Cancer Discov; 2021 Jan; 2(1):19-31. PubMed ID: 34661151
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
